Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer

Cancer Research

Volumn 58, Issue 19, 1998, Pages 4250-4254

  Kornmann, Marko ^a   Maruyama, Haruhisa ^a   Bergmann, Uwe ^b   Tangvoranuntakul, Pam ^a   Beger, Hans G ^b   White, Morris F ^c   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ULM   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCKING PROTEIN; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOGENESIS; NORTHERN BLOTTING; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA ANALYSIS; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PANCREAS; PANCREATIC NEOPLASMS; PHOSPHOPROTEINS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032189403     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. White, M. F., and Kahn, C. R. The insulin signaling system. J. Biol. Chem., 269: 1-5, 1994.
2. Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., and White, M. F. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature (Lond.), 352: 73-77, 1991.
3. Sun, X. J., Wang, L-M., Zhang, Y., Yenush, L., Myers, M. G., Jr., Glasheen, E., Lane, W. S., Pierce, J. H., and White, M. F. Role of IRS-2 in insulin and cytokine signalling. Nature (Lond.), 377: 173-177, 1995.
4. White, M. F. The IRS-signalling system in insulin and cytokine action. Philos. Trans. R. Soc. Lond. B Biol. Sci., 351: 181-189, 1996.
5. Bergmann, U., Funatomi, H., Yokoyama, M., Beger, H. G., and Korc, M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res., 55: 2007-2011, 1995.
6. Bergmann, U., Funatomi, H., Kornmann, M., Beger, H. G., and Korc, M. Increased expression of insulin receptor substrate-1 in human pancreatic cancer. Biochem. Biophys. Res. Commun., 220: 886-890, 1996.
7. Bergmann, U., Funatomi, H., Kornmann, M., Ishiwata, T., Beger, H. G., and Korc, M. Insulin-like growth factor II activates mitogenic signaling in pancreatic cancer cells via IRS-1: in vivo evidence for an islet-cancer cell axis. Int. J. Oncol., 9: 487-492, 1996.
8. Sun, X. J., Pons, S., Wang, L-M., Zhang, Y., Yenush, L., Burks, D., Myers, M. G., Jr., Glasheen, E., Copeland, N. G., Jenkins, N. A., Pierce, J. H., and White, M. F. The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. Mol. Endocrinol., 11: 251-262, 1997.
9. Endemann, G., Yonezawa, K., and Roth, R. A. Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase. J. Biol. Chem., 265: 396-400, 1990.
10. Kornmann, M., Ishiwata, T., Beger, H. G., and Korc, M. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene, 15: 1417-1424, 1997.
11. Haddad, T. C., and Conover, C. A. Insulin and interleukin-4 induce desensitization to the mitogenic effects of insulin-like growth factor-I. J. Biol. Chem., 272: 19525-19531, 1997.
12. Werner, H., and LeRoith, D. The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res., 68: 183-223, 1996.
13. Ihle, J. N. Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic cells. Adv. Cancer Res., 68: 23-65, 1996.
14. Sun, X. J., Miralpeix, M., Myers, M. G., Jr., Glasheen, E. M., Backer, J. M., Kahn, C. R., and White, M. F. The expression and function of IRS-1 in insulin signal transmission. J. Biol. Chem., 267: 22662-22672, 1992.
15. D'Ambrosio, C., Keller, S. R., Morrione, A., Lienhard, G. E., Baserga, R., and Surmacz, E. Transforming potential of the insulin receptor substrate 1. Cell Growth Differ., 6: 557-562, 1995.
16. Tanaka, S., Ito, T., and Wands, J. R. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires and interaction with both Grb2 and Syp signaling molecules. J. Biol. Chem., 271: 14610-14616, 1996.
17. Waters, S. B., Yamauchi, K., and Pessin, J. E. Functional expression of insulin receptor substrate-1 is required for insulin-stimulated mitogenic signaling. J. Biol. Chem., 268: 22231-22234, 1993.
18. Nolan, M. K., Jankowska, L., Prisco, M., Xu, S., Guvakova, M. A., and Surmacz, E. Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells. Int. J. Cancer, 72: 828-834, 1997.
19. Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J. M., Previs, S. Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., Bonner-Weir, S., and White, M. F. Disruption of the IRS-2 gene causes type 2 diabetes in mice. Nature (Lond.), 391: 900-904. 1998.
20. Brüning, J. C., Winnay, J., Cheatham, B., and Kahn, C. R. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in 1RS-1-deficient cells. Mol. Cell. Biol., 17: 1513-1521, 1997.
21. Jackson, J. G., White, M. F., and Yee, D. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells. J. Biol. Chem., 273: 9994-10003, 1998.
22. Zhang, Q., Berggren, P. O., Hansson, A., and Tally, M. Insulin-like growth factor-1-induced DNA synthesis in insulin-secreting cell line RINm5F is associated with phosphorylation of the insulin-like growth factor-I receptor and the insulin receptor substrate-2. J. Endocrinol., 156: 573-581, 1998.
23. Korc, M. Role of growth factors in pancreatic cancer. Surg. Oncol. Clin. N. Am., 7: 25-41, 1998.